Jacobson Mark L.

SEC CIK
0001805812

Latest role at each company

Trades

Every Form 4 that lists Jacobson Mark L. as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
AXSMAxsome Therapeutics, Inc.Sep 3, 20267:09 PM ETSep 3, 2026Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−10K$208.65−$2.09M0−100.0%SEC10b5-1
AXSMAxsome Therapeutics, Inc.May 5, 2026May 4 – May 5, 2026Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−4.75K$227.9518−$1.08M0−100.0%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Feb 27, 2026Feb 26, 2026Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−35.38K$161.88−$5.73M0−100.0%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Sep 22, 2025Sep 22, 2025Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−10K$115.96−$1.16M0−100.0%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Sep 17, 2025Sep 16, 2025Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−45.78K$114.4776−$5.24M0−100.0%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Jun 10, 2025Jun 9, 2025Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−25K$110.44−$2.76M5.78K−81.2%SEC10b5-1
AXSMAxsome Therapeutics, Inc.May 28, 2025May 27 – May 28, 2025Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−40.67K$104.065−$4.23M5.78K−87.6%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Aug 9, 2024Aug 9, 2024Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−47.74K$84.26−$4.02M5.78K−89.2%SEC10b5-1
AXSMAxsome Therapeutics, Inc.May 29, 2024May 29, 2024Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−7.91K$74.31−$587.79K5.78K−57.8%SEC
AXSMAxsome Therapeutics, Inc.Apr 1, 2024Apr 1, 2024Jacobson Mark L.Chief Operating OfficerSSaleCommon Stock−24.66K$77.24−$1.9M0−100.0%SEC10b5-1